To collect post marketing surveillance data on consecutive patients with coronary heart disease intended to be or treated by the drug eluting Support C PTCA balloon catheter when used according to the Instructions for Use. Data will be collected in order to assess the long term safety and performance of the Support C Drug Coated Balloon (DCB) in routine clinical practice.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Consecutive patients intended to be, or treated by Support C DCB as per physicians' decision and according to Instructions for Use (IFU) in the setting of routine clinical care are entered into the registry.
Note:
1. In case of major dissection requiring bailout stenting after DCB use the patients will be included in the registry and followed as per study schedule.
2. If major dissection occurred after lesion preparation, but before DCB use and lesion was stented, the patient will not be included in the registry.
Exclusion Criteria:
* Patients are excluded if ANY of the following additional conditions apply:
* High probability of non-adherence to the follow-up requirements (due to social, psychological or medical reasons)
* Currently participating in another investigational drug or device study in which a routine angiographic follow-up is planned
* A life expectancy of \<1year
* Explicit refusal of participation in the registry
Primary outcome measure(s)
Adjudicated, device-oriented, Target Lesion Failure (TLF) — 12 months post procedure Adjudicated, device-oriented, Target Lesion Failure (TLF) where TLF is defined as a composite of cardiac death (CD), non-fatal myocardial infarction (MI) not clearly attributable to a non-target vessel (TV-MI), or clinically driven target lesion revascularization (cd-TLR) (by PCI or coronary artery bypass grafting).
Trial sites (12)
Facility
City
Region
Status
Krajska nemocnice Liberec
Liberec
Czechia
Motol University Hospital
Prague
Czechia
Katholischen Krankenhaus "St. Johann Nepomuk"
Erfurt
Germany
Evangelisches Krankenhaus Hagen-Haspe gGmbH
Hagen
Germany
MediClin Herzzentrum Lahr
Lahr
Germany
Martha Maria Nürnberg
Nuremberg
Germany
National Heart Institute (Institut Jantung Negara)
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.